General
Preferred name
BROMFENAC
Synonyms
Bromfenac (sodium hydrate) ()
Bromfenac monosodium salt sesquihydrate ()
Bromfenac sodium hydrate ()
BROMFENAC SODIUM ()
Bromfenac (sodium) ()
Lomb-1 ()
bromfenac (low concentration), Bausch & ()
AHR 10282R,Bromsite,Bromday,Prolensa,Xibrom ()
Bromsite, Bromday, Prolensa, Xibrom ()
Bromfenac monosodium salt ()
Bromfenac sodium sesquihydrate ()
Bromsite ()
AHR-10282B ()
Bromday ()
Xibrom ()
Prolensa ()
Bromfenac sodium anhydrous ()
ISV-303 ()
Yellox ()
Bromfenac (sodium salt) ()
Bromfenac-d4 (sodium salt) ()
P&D ID
PD009615
CAS
120638-55-3
91714-94-2
91714-93-1
2749400-35-7
Tags
available
drug
Approved by
FDA
First approval
1997
2005
Drug Status
approved
withdrawn
Drug indication
Inflammation
Postoperative inflammation
Analgesic
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID).
Marketed formulations may contain bromfenac sodium (PubChem CID 23693301). (GtoPdb)
Compound Sets
26
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NPC Screening Collection
Other bioactive compounds
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Withdrawn 2.0
External IDs
71
Properties
(calculated by RDKit )
Molecular Weight
333.0
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
2
Rotatable Bonds
4
Ring Count
2
Aromatic Ring Count
2
cLogP
2.89
TPSA
80.39
Fraction CSP3
0.07
Chiral centers
0.0
Largest ring
6.0
QED
0.67
Structural alerts
1
anthranil_one_A(38)
c:1:c:c:c:c(:c:1-[#7&!H0;!H1,!$([#7]-[#6]=[#8])])-[#6](-[#6]:[#6])=[#8]
PAINS Family B
Custom attributes
(extracted from source data)
Pathway
Immunology/Inflammation
Neuroscience
Target
COX-2
PTGS1, PTGS2
COX
MOA
COX inhibitor
cyclooxygenase inhibitor
ATC
S01BC11
Toxicity type
hepatic
Therapeutic Class
Antiinflammatory Agents
Source data